1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cogstate Limited
  6. Summary
    CGS   AU000000CGS8

COGSTATE LIMITED

(CGS)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-08-09 am EDT
1.800 AUD    0.00%
07/27TRANSCRIPT : Cogstate Limited, Q4 2022 Earnings Call, Jul 28, 2022
CI
07/27COGSTATE : Business Update and June 2022 Quarter Cashflow
PU
06/20COGSTATE : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer's Disease
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
1.85(c) 1.85(c) 1.825(c) 1.8(c) 1.8 Last
266 933 106 423 63 043 498 433 197 423 Volume
+1.65% 0.00% -1.35% -1.37% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2022 65,3 M 45,7 M 45,7 M
Net income 2022 11,3 M 7,88 M 7,88 M
Net cash position 2022 38,2 M 26,8 M 26,8 M
P/E ratio 2022 27,6x
Yield 2022 -
Sales 2023 78,5 M 55,0 M 55,0 M
Net income 2023 13,3 M 9,30 M 9,30 M
Net cash position 2023 48,0 M 33,6 M 33,6 M
P/E ratio 2023 23,4x
Yield 2023 -
Capitalization 312 M 218 M 218 M
EV / Sales 2022 4,19x
EV / Sales 2023 3,36x
Nbr of Employees 171
Free-Float 47,0%
More Financials
Company
Cogstate Ltd is an Australia-based neuroscience technology company. The Company optimizes brain health assessments to develop new medicines and to enable earlier clinical insights in healthcare. The Company’s technologies provide computerized cognitive tests across a list of domains and support electronic clinical outcome assessment (eCOA) solutions. The Company operates through two segments: Clinical Trials and... 
More about the company
All news about COGSTATE LIMITED
07/27TRANSCRIPT : Cogstate Limited, Q4 2022 Earnings Call, Jul 28, 2022
CI
07/27COGSTATE : Business Update and June 2022 Quarter Cashflow
PU
06/20COGSTATE : Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Mea..
PU
06/14Cogstate Announces Formation of Scientific Advisory Board
GL
06/14Cogstate Announces Formation of Scientific Advisory Board
CI
06/14COGSTATE : Announces Formation of Scientific Advisory Board
PU
05/26Cogstate Ltd. Announces Change of Registered Office and Principal Place of Business
CI
04/20COGSTATE : Investor Update
PU
04/20COGSTATE : Business Update and March 2022 Quarter Cashflow
PU
03/20COGSTATE LIMITED(ASX : CGS) added to S&P/ASX All Ordinaries Index
CI
03/20COGSTATE LIMITED(ASX : CGS) added to S&P/ASX Emerging Companies Index
CI
02/24TRANSCRIPT : Cogstate Limited, H1 2022 Earnings Call, Feb 24, 2022
CI
02/23COGSTATE : Half Year Report – H1 FY2022
PU
02/23COGSTATE : 1H22 Financial Results & Business Update
PU
02/23COGSTATE : Investor Briefing
PU
More news
News in other languages on COGSTATE LIMITED
06/14Cogstate annonce la formation d'un conseil consultatif scientifique
02/23Cogstate Limited annonce ses résultats pour le semestre clos le 31 décembre 2021
01/20Cogstate enregistre une hausse de 40 % de son chiffre d'affaires au deuxième trimestre ..
01/12Cogstate commercialise sa technologie directement auprès des consommateurs à Taïwan et ..
2021Cogstate réalise un bénéfice pour l'exercice 21 grâce à une hausse du chiffre d'affaire..
More news
Chart COGSTATE LIMITED
Duration : Period :
Cogstate Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COGSTATE LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,80 AUD
Average target price 2,46 AUD
Spread / Average Target 36,9%
EPS Revisions
Managers and Directors
Bradley John O'Connor Chief Executive Officer, Executive Director & MD
Darren Watson Chief Financial Officer
Martyn Kenneth Myer Non-Executive Chairman
Chris Edgar Chief Scientific Officer
Benjamin Bloomfield Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
COGSTATE LIMITED-25.62%218
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.80%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235